Search research articles
Contact Us
Filters
Showing results (461-470 of 470) with videos related to
Page
of 47
Sort By:
You have reached the last page of results.
This site can display upto 470 results.
Preparative Biochemistry & Biotechnology
|
May 11, 2005
Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions
R Murphy, S Green, G Ritter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2001
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial
A M Scott, F T Lee, W Hopkins, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 21, 2008
Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant
Sylvia Adams, David W O'Neill, Daisuke Nonaka, et al.
Breast Cancer Research and Treatment
|
June 8, 2011
Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways
Catherine Ibarra-Drendall, Michelle M Troch, William T Barry, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2007
A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors
Andrew M Scott, Fook-Thean Lee, Niall Tebbutt, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 15, 2004
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans
Ian D Davis, Weisan Chen, Heather Jackson, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
January 26, 2019
Recommendations towards standards for quantitative MRI (qMRI) and outstanding needs
Kathryn E Keenan, Joshua R Biller, Jana G Delfino, et al.
Science Translational Medicine
|
June 7, 2019
Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance
Elise M N Ferré, Timothy J Break, Peter D Burbelo, et al.
Science (New York, N.Y.)
|
September 16, 2021
Response to Comments on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections"
Timothy J Break, Vasileios Oikonomou, Nicolas Dutzan, et al.
Science (New York, N.Y.)
|
January 15, 2021
Aberrant type 1 immunity drives susceptibility to mucosal fungal infections
Timothy J Break, Vasileios Oikonomou, Nicolas Dutzan, et al.
Page
of 47
Search research articles
Search
Showing results (461-470 of 470) with videos related to
Sort By:
Page
of 47
You have reached the last page of results.
This site can display upto 470 results.
Preparative Biochemistry & Biotechnology
|
May 11, 2005
Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions
R Murphy, S Green, G Ritter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2001
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial
A M Scott, F T Lee, W Hopkins, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 21, 2008
Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant
Sylvia Adams, David W O'Neill, Daisuke Nonaka, et al.
Breast Cancer Research and Treatment
|
June 8, 2011
Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways
Catherine Ibarra-Drendall, Michelle M Troch, William T Barry, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2007
A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors
Andrew M Scott, Fook-Thean Lee, Niall Tebbutt, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 15, 2004
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans
Ian D Davis, Weisan Chen, Heather Jackson, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
January 26, 2019
Recommendations towards standards for quantitative MRI (qMRI) and outstanding needs
Kathryn E Keenan, Joshua R Biller, Jana G Delfino, et al.
Science Translational Medicine
|
June 7, 2019
Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance
Elise M N Ferré, Timothy J Break, Peter D Burbelo, et al.
Science (New York, N.Y.)
|
September 16, 2021
Response to Comments on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections"
Timothy J Break, Vasileios Oikonomou, Nicolas Dutzan, et al.
Science (New York, N.Y.)
|
January 15, 2021
Aberrant type 1 immunity drives susceptibility to mucosal fungal infections
Timothy J Break, Vasileios Oikonomou, Nicolas Dutzan, et al.
Page
of 47